Strain Profile
Save

Bifidobacterium breve MCC1274

◔ Human-origin
Sequenced
Public genome assembly available

Bifidobacterium breve MCC1274 has an emerging body of research focused primarily on brain-gut interactions and cognitive health. A 24-week randomized, double-blind, placebo-controlled trial in older adults with suspected mild cognitive impairment examined cognitive function scores and brain atrophy measures as outcomes. Animal studies using APP knock-in mouse models of Alzheimer's disease have examined this strain in relation to amyloid-beta production and microglial activation, including possible metabolite pathways involving tryptophan derivatives and oxidative stress. In vitro work has explored metabolite profiles when the strain is co-cultured with intestinal epithelial cells. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 23 body-system-tagged papers that concern each system. Research coverage, not measured effect.

Symptoms in the research

Share of this strain's 2 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

Research

25 papers reference this strain in the probiotic database.

Match confidence
2026 ANIMAL
Dietary silver nanoparticle supplementation induces Alzheimer-like lesions through Bifidobacterium deficiency-dominated gut microbiota dysbiosis and neuroinflammation
· npj Science of Food
2025 IN_VITRO
Effect of the manufacturing process on bifidobacteria survival in ice cream
· Nippon Shokuhin Kagaku Kogaku Kaishi
2025 REVIEW
Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer’s Disease
· Nutrients
2024 ANIMAL
Potential Therapeutic Effects of Bifidobacterium breve MCC1274 on Alzheimer’s Disease Pathologies in AppNL-G-F Mice
· Nutrients
2024 ANIMAL
Oral Administration of Probiotic Bifidobacterium breve Ameliorates Tonic–Clonic Seizure in a Pentylenetetrazole-Induced Kindling Mouse Model via Integrin-Linked Kinase Signaling
· International Journal of Molecular Sciences
2024 REVIEW
Extending Healthy Life Expectancy Through the Study of Brain-Gut-Microbiota Axis
· KAGAKU TO SEIBUTSU
2024 RCT
Effects of Bifidobacterium longum BB536 and Bifidobacterium breve MCC1274 on Body Composition in Normal and Overweight Adults in Randomized Placebo-Controlled Study
· Nutrients
2023 IN_VITRO
Comprehensive analysis of metabolites produced by co-cultivation of Bifidobacterium breve MCC1274 with human iPS-derived intestinal epithelial cells
· Frontiers in Microbiology
2023 IN_VITRO
Probiotic Bifidobacterium breve MCC1274 Protects against Oxidative Stress and Neuronal Lipid Droplet Formation via PLIN4 Gene Regulation
· Microorganisms
2022 ANIMAL
Probiotic Bifidobacterium breve MCC1274 Mitigates Alzheimer’s Disease-Related Pathologies in Wild-Type Mice
· Nutrients
2022 ANIMAL
Bifidobacterium breve MCC1274 Supplementation Increased the Plasma Levels of Metabolites with Potential Anti-Oxidative Activity in APP Knock-In Mice
· Journal of Alzheimer s Disease
2022 IN_VITRO
Synbiotics of Bifidobacterium breve MCC1274 and lactulose enhances production of tryptophan metabolites in fermented human fecal communities
· Food Research International
2022 RCT
Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial
· Journal of Alzheimer s Disease
2021 ANIMAL
Probiotic Bifidobacterium breve Prevents Memory Impairment Through the Reduction of Both Amyloid-β Production and Microglia Activation in APP Knock-In Mouse
· Journal of Alzheimer s Disease
2021 ANIMAL
Oral Administration of Probiotic Bifidobacterium breve Improves Facilitation of Hippocampal Memory Extinction via Restoration of Aberrant Higher Induction of Neuropsin in an MPTP-Induced Mouse Model of Parkinson’s Disease
· Biomedicines
2021 ANIMAL
Probiotic Bifidobacterium breve decreases Aβ production via the upregulation of ADAM10 level and attenuates microglia activation in an APP knock‐in mouse model of Alzheimer’s disease
· Alzheimer s & Dementia
2021 RCT
Anti‐inflammation as one of the mechanisms in the improvement of cognitive function by probiotic Bifidobacterium breve strain
· Alzheimer s & Dementia
2021 OBSERVATIONAL
Lipid and Energy Metabolism of the Gut Microbiota Is Associated with the Response to Probiotic Bifidobacterium breve Strain for Anxiety and Depressive Symptoms in Schizophrenia
· Journal of Personalized Medicine
2021 RCT
Association of Plasma Hemoglobin A1c with Improvement of Cognitive Functions by Probiotic Bifidobacterium breve Supplementation in Healthy Adults with Mild Cognitive Impairment
· Journal of Alzheimer s Disease
2020 RCT
Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial
· Journal of Alzheimer s Disease
Browse all 25 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Dietary silver nanoparticle supplementation induces Alzheimer-like lesions through Bifidobacterium deficiency-dominated gut microbiota dysbiosis and neuroinflammation
    · npj Science of Food · 2026
    PMID 41935066 →
  2. [2]
    Association of Plasma Hemoglobin A1c with Improvement of Cognitive Functions by Probiotic Bifidobacterium breve Supplementation in Healthy Adults with Mild Cognitive Impairment
    · Journal of Alzheimer s Disease · 2021
    PMID 33814441 →
  3. [3]
    Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial
    · Journal of Alzheimer s Disease · 2020
    PMID 32623402 →